LidoSpra

Manufacturer
Oncora Pharma, LLC
Effective date
2026-08-25
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-08-27 00:02:34

Label at a glance#

ProductLidoSpra
Active ingredientLIDOCAINE
Label structure8 sections

Indications and uses

LidoSpra™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.

Dosage and administration

Spray the affected area in sufficient quantity 2 to 4 times daily as needed or as directed by a healthcare provider.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

LidoSpra™ is a topical spray containing Lidocaine 4.12%.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

LidoSpra™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

LidoSpra™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.

WARNINGS

WARNINGS SECTION

For external use only. Avoid contact with eyes. If irritation, sensitivity, or infection occurs, discontinue use. Keep out of reach of children.

PRECAUTIONS

PRECAUTIONS SECTION

Use only as directed. Excessive application may result in increased systemic absorption of lidocaine.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Spray the affected area in sufficient quantity 2 to 4 times daily as needed or as directed by a healthcare provider.

REFERENCES

HOW SUPPLIED SECTION

LidoSpra™ (Lidocaine 4.12%) is supplied as a topical spray in a 30 mL (1 fl oz) container.

NDC 85477-325-29

Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdp
pdp

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130854770325296GTIN-13: 0854770325296
EAN-13: 0854770325296
GTIN-12: 854770325296
UPC-A: 854770325296
GTIN storage (14 digits): 00854770325296
lidospra-1.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85477-32585477-325-29

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LidoSpraLIDOSPRAOncora Pharma, LLC0f1a2c0d-d5d3-4b8f-94f6-0a01b46269592026-08-25WarningsExact identifier
ndc (package): 85477-325-29
ndc (product): 85477-325
ndc11 (package): 85477032529
spl id: 3b70d486-5f9e-4155-a206-a4de77c93b33
spl set id: 0f1a2c0d-d5d3-4b8f-94f6-0a01b4626959

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.